H.C. Wainwright raised the firm’s price target on Balchem (BCPC) to $190 from $185 and keeps a Buy rating on the shares post the Q3 report. The firm continues to consider Balchem a bright spot within the human and animal nutrition and health arena.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.